Your search returned 48 results.

Sort
Results
1.
Replication of the Association of BDNF and MC4R Variants With Dietary Intake in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27551991
Year: 2017
Citation:
  • Psychosomatic Medicine. 79(2):224-233, 2017 Feb/Mar
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda V, Barrett-Connor E, Dagogo-Jack S, Delahanty LM, Diabetes Prevention Program Research Group, Florez JC, Franks PW, Hamman RF, Horton ES, Jablonski KA, Kitabchi A, Knowler WC, Marrero D, McCaffery JM, Wing RR, Wylie-Rosett J
2.
Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29686453
Year: 2018
Citation:
  • Cd (Clinical Diabetes). 36(2):138-147, 2018 Apr
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Arulandu JR, Cannon AJ
3.
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386912
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
4.
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31189519
Year: 2019
Citation:
  • The Lancet Diabetes & Endocrinology. 7(8):596-605, 2019 08.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Gonzalez-Galvez G, Gron R, Halladin N, Haluzik M, Jermendy G, Kok A, Orsy P, Sabbah M, Sesti G, Silver R
5.
Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 33468520
Year: 2021
Citation:
  • Diabetes Care. 44(3):774-780, 2021 03.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Birkenfeld AL, Blonde L, Del Prato S, Frias J, Ji C, Niemoeller E, Rosenstock J, Souhami E
6.
Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 37094945
Year: 2023
Citation:
  • BMJ Open Diabetes Research & Care. 11(2), 2023 04.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • AbouAssi H, Ahmann AJ, Aroda VR, Butera NM, Desouza C, Green JB, Gulanski BI, Harindhanavudhi T, Krause-Steinrauf H, Lichtman JH, Suratt CE, Wexler DJ
7.
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386990
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
8.
Testosterone and depressive symptoms among men in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27371769
Year: 2016
Citation:
  • Psychoneuroendocrinology. 72:63-71, 2016 Oct
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Barrett-Connor E, Bray GA, Christophi CA, Diabetes Prevention Program Research Group, Golden SH, Horton ES, Kim C, Labrie F, Mather KJ, Pi-Sunyer X
9.
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31359368
Year: 2019
Citation:
  • Advances in Therapy. 36(9):2310-2326, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Blonde L, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M
10.
Long-term effects of lifestyle and metformin interventions in DPP on bone density. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 34086101
Year: 2021
Citation:
  • Osteoporosis International. 2021 Jun 04
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Crandall JP, Diabetes Prevention Program Research Group, Florez H, Kriska A, Pan Q, Piromalli C, Schwartz AV, Temprosa M, Wallia A
11.
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials. [Review] MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29364586
Year: 2018
Citation:
  • Diabetes, Obesity & Metabolism. 20 Suppl 1:22-33, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR
12.
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 32139384
Year: 2020
Citation:
  • Diabetes Care. 43(5):940-947, 2020 05.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
13.
Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 25024396
Year: 2014
Citation:
  • Diabetes Care. 37(10):2738-45, 2014 Oct.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bray GA, Delahanty LM, Diabetes Prevention Program Research Group, Florez JC, Franks PW, Jablonski KA, Kahn SE, Pan Q, Perreault L, Watson KE
14.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27284114
Year: 2016
Citation:
  • Diabetes Care. 39(9):1579-86, 2016 Sep
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
15.
Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29220533
Year: 2018
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 103(2):486-496, 2018 02 01.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Carrion-Petersen M, Diabetes Prevention Program Outcomes Study Group, Edelstein SL, Ehrmann DA, Goldberg RB, Kim C, Younes N
16.
Reproducibility of a prediabetes classification in a contemporary population. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 32812912
Year: 2020
Citation:
  • Metabolism Open. 6:100031, 2020 Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Brodsky I, Chadha C, Chatterjee R, D2d Research Group, Knowler WC, Lary CW, Lewis MR, Nelson J, Phillips LS, Pittas AG, Pratley R, Rasouli N, Staten MA
17.
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 34008442
Year: 2021
Citation:
  • Journal of Diabetes Science & Technology. :19322968211016513, 2021 May 19
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bergenstal RM, Brazg RL, Dreon DM, Frias JP, Johnson ML, Kruger DF, Levy BL, Molitch ME, Mullen DM, Peyrot M, Richter S, Rosenstock J, Serusclat P, Vance C, Weinstock RS
18.
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530665
Year: 2019
Citation:
  • Diabetes Care. 42(11):2108-2116, 2019 11.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
19.
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29246950
Year: 2018
Citation:
  • Diabetes Care. 41(2):258-266, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
20.
Lower skin cancer risk in women with higher body mass index: the women's health initiative observational study. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 24042260
Year: 2013
Citation:
  • Cancer Epidemiology, Biomarkers & Prevention. 22(12):2412-5, 2013 Dec.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Aroda V, Desai M, Henderson MT, Hernandez-Boussard T, Kubo J, McTiernan A, Sims ST, Stefanick ML, Tang JY, Thomas F
21.
Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 25023634
Year: 2014
Citation:
  • Circulation. Cardiovascular Genetics. 7(4):505-13, 2014 Aug.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Aroda V, Bhattacharjee S, Carlson CS, Carty CL, Chatterjee N, Cheng I, Haessler J, Hindorff LA, Hsu CN, Jackson R, Kooperberg C, Liu S, North KE, Pankow JS, Peters U, Selvin E, Wilkens L
22.
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. [Review] MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28770322
Year: 2017
Citation:
  • Diabetologia. 60(9):1601-1611, 2017 Sep.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Crandall JP, Darwin C, Diabetes Prevention Program Research Group, Edelstein SL, Heckman-Stoddard BM, Jeffries SL, Kahn SE, Knowler WC, Molitch ME, Nathan DM, Perreault L, Pi-Sunyer X, Temprosa M
23.
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors:
  • Aroda, Vanita R
PMID:
  • 26990378
Year: 2016
Citation:
  • Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J
24.
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29397376
Year: 2018
Citation:
  • The Lancet Diabetes & Endocrinology. 6(4):275-286, 2018 04.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Andreassen C, Aroda VR, Lingvay I, Ludemann J, Navarria A, Pratley RE, SUSTAIN 7 investigators, Viljoen A
25.
Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31007049
Year: 2019
Citation:
  • Clinical Trials. 16(3):306-315, 2019 06.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Brodsky IG, Chadha C, Chatterjee R, D2d Research Group, Desouza C, LeBlanc ES, Ouellette MG, Phillips LS, Pittas AG, Sheehan PR, Staten MA, Vickery EM
26.
A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31903724
Year: 2020
Citation:
  • Diabetes, Obesity & Metabolism. 2020 Jan 05
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bardtrum L, Dagdelen S, Halladin N, Haluzik M, Orsy P, Rodriguez M, Sesti G
27.
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31186300
Year: 2019
Citation:
  • Diabetes Care. 42(9):1724-1732, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Altuntas Y, Aroda VR, Christiansen E, Haluzik M, Hertz CL, Jeppesen OK, Lalic NM, Morales Villegas EC, PIONEER 1 Investigators, Rosenstock J, Terauchi Y
28.
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 26200237
Year: 2015
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 100(10):3778-86, 2015 Oct.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Barrett-Connor E, Christophi CA, Diabetes Prevention Program, Edelstein SE, Florez JC, Goldberg RB, Kahn SE, Kim C, Knowler WC, Labrie F, Mather KJ
29.
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28058769
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. , 2017 Jan 06
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Han J, Hardy E, Horowitz M, Rayner CK
30.
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 26900641
Year: 2016
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 101(4):1754-61, 2016 Apr
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bray GA, Crandall JP, Diabetes Prevention Program Research Group, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Schade DS, Temprosa MG, White NH
31.
Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28833481
Year: 2017
Citation:
  • Diabetic Medicine. 34(12):1747-1755, 2017 Dec.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Knowler WC, Mather KJ, Pan Q, Perreault L, The Diabetes Prevention Program Research Group
32.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27650977
Year: 2016
Citation:
  • Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
33.
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28344112
Year: 2017
Citation:
  • The Lancet Diabetes & Endocrinology. 5(5):355-366, 2017 May
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Axelsen M, Bain SC, Cariou B, DeVries JH, Piletic M, Rose L, Rowe E
34.
Response to Letter: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29546419
Year: 2018
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 2018 Mar 12
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Carrion-Petersen M, Diabetes Prevention Program Outcomes Study Group, Edelstein SL, Ehrmann DA, Goldberg RB, Kim C, Younes N
35.
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28939018
Year: 2017
Citation:
  • Journal of Diabetes & its Complications. 31(12):1719-1727, 2017 Dec.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Gourgari E, Hassanzadeh H, Shoulson I, Wilhelm EE
36.
Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31025878
Year: 2019
Citation:
  • Diabetes Technology & Therapeutics. 21(5):273-285, 2019 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Bergenstal RM, Brazg RL, Calibra Study Group, Dreon DM, Frias JP, Johnson ML, Klonoff DC, Kruger DF, Levy BL, Naik RG, Peyrot M, Ramtoola S, Rosenstock J, Serusclat P, Shearer DM, Weinstock RS, Zraick V
37.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530667
Year: 2019
Citation:
  • Diabetes Care. 42(12):2262-2271, 2019 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
38.
Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 33328161
Year: 2020
Citation:
  • BMJ Open Diabetes Research & Care. 8(2), 2020 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Christophi CA, DPP Research Group, Edelstein SL, Golden SH, Horton E, Kim C, Mather KJ, Perreault L
39.
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). MedStar authors:
  • Aroda, Vanita R
  • Kuhn, Alexander
PMID:
  • 31391203
Year: 2019
Citation:
  • Diabetes Care. 42(11):2098-2107, 2019 Nov.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Crandall JP, Florez HJ, GRADE Research Group, Hox SH, Krause-Steinrauf H, Kuhn A, Sood A, Underkofler C, Wexler DJ
40.
Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative. MedStar authors:
  • Aroda, Vanita R
  • Sullivan, Shannon D
PMID:
  • 27465714
Year: 2017
Citation:
  • Menopause. 24(1):64-72, 2017 Jan
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Anderson M, Aroda V, Desai M, Hedlin H, Kapphahn K, LeBlanc ES, Lewis CE, Liu S, Parikh NI, Parker DR, Stefanick M, Sullivan S, Waring ME, Woods NF
41.
Differences in complications, cardiovascular risk factor, and diabetes management among participants enrolled at veterans affairs (VA) and non-VA medical centers in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE). MedStar authors:
  • Aroda, Vanita R
  • Park, Jean
PMID:
  • 34971663
Year: 2022
Citation:
  • Diabetes Research & Clinical Practice. 184:109188, 2022 Feb.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Florez HJ, Ghosh A, GRADE Research Group, Hox SH, Killean T, Krause-Steinrauf H, McKee MD, Park J, Pop-Busui R, Rhee MK, Underkofler C, Wexler DJ
42.
Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. MedStar authors:
  • Aroda, Vanita R
  • Getaneh, Asqual
PMID:
  • 30293496
Year: 2015
Citation:
  • Expert Review of Endocrinology & Metabolism. 10(4):381-398, 2015 Jul.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Getaneh A
43.
Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale. [Review] MedStar authors:
  • Aroda, Vanita R
  • Yassin, Sayf A
PMID:
  • 28356718
Year: 2017
Citation:
  • Drug design, development & therapy. 11:923-937, 2017
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Yassin SA
44.
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. MedStar authors:
  • Aroda, Vanita R
  • Ratner, Robert E
PMID:
  • 25706240
Year: 2015
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 100(4):1646-53, 2015 Apr.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Observational Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Ackermann RT, Aroda VR, Barrett-Connor E, Christophi CA, Delahanty LM, Diabetes Prevention Program Research Group, Edelstein SL, Herman WH, Knowler WC, Montez MG, Ratner RE, Zhang P, Zhuo X
45.
Vitamin D Supplementation and Prevention of Type 2 Diabetes. MedStar authors:
  • Aroda, Vanita R
  • Ghazi, Adline
  • Park, Jean
PMID:
  • 31173679
Year: 2019
Citation:
  • New England Journal of Medicine. 2019 Jun 07
Institution:
  • MedStar Good Samaritan Hospital
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, D2d Research Group, Dawson-Hughes B, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, Knowler WC, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pittas AG, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Sheehan P, Staten M, Vickery EM, Ware JH
46.
Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?. [Review] MedStar authors:
  • Aroda, Vanita R
  • Ghazi, Adline
  • Kuhn, Alexander
  • Park, Jean
PMID:
  • 28251513
Year: 2017
Citation:
  • Current Cardiology Reports. 19(3):25, 2017 Mar
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Ghazi A, Kuhn A, Park J
47.
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program. [Review] MedStar authors:
  • Aroda, Vanita R
  • Peng, Hui
  • Want, Laura L
PMID:
  • 27037706
Year: 2016
Citation:
  • Current Diabetes Reports. 16(5):44, 2016 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Peng H, Want LL
48.
Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. MedStar authors:
  • Aroda, Vanita R
  • Fernandez, Stephen J
  • Ratner, Robert E
PMID:
  • 23305087
Year: 2013
Citation:
  • Diabetes Technology & Therapeutics. 15(2):117-23, 2013 Feb.
Institution:
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Conway BN, Fernandez SJ, Matter NI, Maynard JD, Orchard TJ, Ratner RE
Pages

Powered by Koha